Published in J Neurophysiol on January 11, 2006
Repeated-slip training: an emerging paradigm for prevention of slip-related falls among older adults. Phys Ther (2007) 1.96
Role of stability and limb support in recovery against a fall following a novel slip induced in different daily activities. J Biomech (2009) 1.31
Inoculation against falls: rapid adaptation by young and older adults to slips during daily activities. Arch Phys Med Rehabil (2010) 1.24
Predicted threshold against backward balance loss following a slip in gait. J Biomech (2008) 1.17
Automatic recognition of falls in gait-slip training: Harness load cell based criteria. J Biomech (2011) 1.16
Generalization of gait adaptation for fall prevention: from moveable platform to slippery floor. J Neurophysiol (2008) 1.14
Immediate and latent interlimb transfer of gait stability adaptation following repeated exposure to slips. J Mot Behav (2008) 1.12
Generalization of motor adaptation to repeated-slip perturbation across tasks. Neuroscience (2011) 1.03
Effects of moveable platform training in preventing slip-induced falls in older adults. Ann Biomed Eng (2011) 1.01
Determination of instantaneous stability against backward balance loss: two computational approaches. J Biomech (2008) 0.99
Learning from laboratory-induced falling: long-term motor retention among older adults. Age (Dordr) (2014) 0.97
Learning to resist gait-slip falls: long-term retention in community-dwelling older adults. Arch Phys Med Rehabil (2012) 0.96
Prevention of slip-related backward balance loss: the effect of session intensity and frequency on long-term retention. Arch Phys Med Rehabil (2009) 0.95
Can observational training substitute motor training in preventing backward balance loss after an unexpected slip during walking? J Neurophysiol (2007) 0.89
Role of individual lower limb joints in reactive stability control following a novel slip in gait. J Biomech (2009) 0.89
Adaptability to perturbation as a predictor of future falls: a preliminary prospective study. J Geriatr Phys Ther (2010) 0.87
Perturbation training can reduce community-dwelling older adults' annual fall risk: a randomized controlled trial. J Gerontol A Biol Sci Med Sci (2014) 0.85
Alteration in community-dwelling older adults' level walking following perturbation training. J Biomech (2013) 0.83
Control of dynamic stability during gait termination on a slippery surface in Parkinson's disease. Mov Disord (2008) 0.82
Control of dynamic stability during adaptation to gait termination on a slippery surface. Exp Brain Res (2009) 0.81
Adaptation and generalization to opposing perturbations in walking. Neuroscience (2013) 0.81
Effects of perturbation-based slip training using a virtual reality environment on slip-induced falls. Ann Biomed Eng (2014) 0.80
Adaptation of gait termination on a slippery surface in Parkinson's disease. Gait Posture (2012) 0.78
Intensity and generalization of treadmill slip training: High or low, progressive increase or decrease? J Biomech (2015) 0.78
Learning from falling: retention of fall-resisting behavior derived from one episode of laboratory-induced slip training. J Am Geriatr Soc (2011) 0.77
Assessing preparative gait adaptations in persons with transtibial amputation in response to repeated medial-lateral perturbations. Gait Posture (2013) 0.76
Reactive control and its operation limits in responding to a novel slip in gait. Ann Biomed Eng (2010) 0.76
Retention of the "first-trial effect" in gait-slip among community-living older adults. Geroscience (2017) 0.75
Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (2000) 15.53
Assessing the clinical effectiveness of preventive maneuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. A report by the Canadian Task Force on the Periodic Health Examination. J Clin Epidemiol (1990) 3.88
Simultaneous genotyping and species identification using hybridization pattern recognition analysis of generic Mycobacterium DNA arrays. Genome Res (1998) 3.85
Evidence that the src gene product of Rous sarcoma virus is membrane associated. Virology (1980) 3.71
Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci (2002) 3.28
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet (1994) 3.12
Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04
Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (1992) 3.03
Functions of cytoplasmic fibers in intracellular movements in BHK-21 cells. J Cell Biol (1978) 2.74
New approaches for studying and exploiting an old protuberance, the plant trichome. Ann Bot (2004) 2.54
Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc Natl Acad Sci U S A (1996) 2.50
Changes in microfilament organization and surface topogrophy upon transformation of chick embryo fibroblasts with Rous sarcoma virus. Proc Natl Acad Sci U S A (1976) 2.38
Phorbol myristate acetate stimulates microtubule and 10-nm filament extension and lysosome redistribution in mouse macrophages. J Cell Biol (1980) 2.31
Determinants of increased energy expenditure in HIV-infected women. Am J Clin Nutr (1998) 2.21
Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol (1997) 2.19
Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J Clin Invest (1993) 2.18
Role of pretransplant echocardiographic evaluation in predicting outcomes following liver transplantation. Am J Transplant (2013) 2.04
Definition of distinct compartments in polarized Madin-Darby canine kidney (MDCK) cells for membrane-volume sorting, polarized sorting and apical recycling. Traffic (2000) 2.00
Advantages of mRNA amplification for microarray analysis. Biotechniques (2002) 2.00
Interleukin 12 at the site of disease in tuberculosis. J Clin Invest (1994) 1.98
Differences in intracellular location of pp60src in rat and chicken cells transformed by Rous sarcoma virus. Proc Natl Acad Sci U S A (1980) 1.91
Phorbol myristate acetate stimulates pinocytosis and membrane spreading in mouse peritoneal macrophages. J Cell Biol (1980) 1.88
Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. Ultrasound Obstet Gynecol (2012) 1.83
Adaptive control of gait stability in reducing slip-related backward loss of balance. Exp Brain Res (2005) 1.78
Involvement of microtubules and 10-nm filaments in the movement and positioning of nuclei in syncytia. J Cell Biol (1979) 1.78
Genetic variation in the 3' non-coding region of dengue viruses. Virology (2001) 1.71
Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr (1992) 1.71
PHACES association: a neuroradiologic review of 17 patients. AJNR Am J Neuroradiol (2008) 1.70
Fibrillar systems in cell motility. Ciba Found Symp (1973) 1.70
Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens. J Immunol (1999) 1.67
Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα. J Clin Invest (2014) 1.66
Interferon effects on microfilament organization, cellular fibronectin distribution, and cell motility in human fibroblasts. J Cell Biol (1980) 1.65
Enzymology of long-chain base synthesis by liver: characterization of serine palmitoyltransferase in rat liver microsomes. Arch Biochem Biophys (1984) 1.62
Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression. J Immunol (1999) 1.58
Flexible use of high-density oligonucleotide arrays for single-nucleotide polymorphism discovery and validation. Genome Res (2001) 1.55
Leukocyte counts and colonization with Ureaplasma urealyticum in preterm neonates. Clin Infect Dis (1993) 1.54
Structure and expression of a membrane component of the inhibin receptor system. Endocrinology (2000) 1.53
Cytoplasmic localization of the transforming protein of Fujinami sarcoma virus: salt-sensitive association with subcellular components. J Virol (1983) 1.52
Quantitation of free sphingosine in liver by high-performance liquid chromatography. Anal Biochem (1988) 1.51
Binding of deoxyribonuclease I to actin: a new way to visualize microfilament bundles in nonmuscle cells. J Histochem Cytochem (1978) 1.50
Acupuncture for neck disorders. Cochrane Database Syst Rev (2006) 1.50
Amplified C lambda and c-abl genes are on the same marker chromosome in K562 leukemia cells. Proc Natl Acad Sci U S A (1983) 1.48
The Epstein-Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression. Proc Natl Acad Sci U S A (1998) 1.47
Suicide substrates for the alanine racemase of Escherichia coli B. Biochemistry (1978) 1.47
Improvements to the differential display method for gene analysis. Biochem Biophys Res Commun (1994) 1.46
The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;Nras(G12D) acute myeloid leukemia. Oncogene (2012) 1.46
Tyrosine phosphorylation in human neutrophil. Biochem Biophys Res Commun (1989) 1.45
Proton nuclear magnetic resonance assignments and structural characterization of an intramolecular DNA triplex. J Mol Biol (1992) 1.41
BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1. J Cell Physiol (2001) 1.40
Influence of gait speed on stability: recovery from anterior slips and compensatory stepping. Gait Posture (2005) 1.39
BK virus replication and nephropathy after alemtuzumab-induced kidney transplantation. Am J Transplant (2012) 1.38
Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide. J Biol Chem (1997) 1.37
Obesity and obesity-related secondary conditions in adolescents with intellectual/developmental disabilities. J Intellect Disabil Res (2010) 1.37
Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab (1997) 1.36
Immune selection after antigen-specific immunotherapy of melanoma. Surgery (1999) 1.34
Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer. Br J Cancer (2009) 1.33
Rotavirus-associated diarrhea in outpatient settings and child care centers. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med (2000) 1.32
Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. J Gene Med (2000) 1.32
Apoptosis rate can be accelerated or decelerated by overexpression or reduction of the level of elongation factor-1 alpha. Exp Cell Res (1998) 1.30
High-frequency S-layer protein variation in Campylobacter fetus revealed by sapA mutagenesis. Mol Microbiol (1994) 1.29
Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins. Environ Health Perspect (2001) 1.29
Hospitalization for community-acquired, rotavirus-associated diarrhea: a prospective, longitudinal, population-based study during the seasonal outbreak. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med (2000) 1.28
A high-performance liquid chromatographic method to measure sphingosine 1-phosphate and related compounds from sphingosine kinase assays and other biological samples. Anal Biochem (2000) 1.28
Tissue-specific expression in mammalian brain, heart, and muscle of S1, a member of the elongation factor-1 alpha gene family. J Biol Chem (1992) 1.27
Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and Toll-like receptor 4. J Biol Chem (2011) 1.27
Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. J Biol Chem (1993) 1.25
High prevalence of rare dopamine receptor D4 alleles in children diagnosed with attention-deficit hyperactivity disorder. Mol Psychiatry (2003) 1.24
Sequences within the spacer region of yeast rRNA cistrons that stimulate 35S rRNA synthesis in vivo mediate RNA polymerase I-dependent promoter and terminator activities. Mol Cell Biol (1989) 1.24
Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100. J Immunother (2000) 1.24
Hyperosmotic stress stimulates promoter activity and regulates cellular utilization of the serum- and glucocorticoid-inducible protein kinase (Sgk) by a p38 MAPK-dependent pathway. J Biol Chem (2000) 1.22
Interferon suppresses pinocytosis but stimulates phagocytosis in mouse peritoneal macrophages: related changes in cytoskeletal organization. J Cell Biol (1984) 1.22
Characterization of elongation factor-1A (eEF1A-1) and eEF1A-2/S1 protein expression in normal and wasted mice. J Biol Chem (2001) 1.21
Regulation of phosphatidate phosphatase activity from the yeast Saccharomyces cerevisiae by sphingoid bases. J Biol Chem (1993) 1.20
Structure-activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobiotic-metabolizing enzymes in rats and mice. Carcinogenesis (1993) 1.18
Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma. Cell Death Dis (2013) 1.16
Long-term retention of gait stability improvements. J Neurophysiol (2005) 1.14
Identification of glial filament protein and vimentin in the same intermediate filament system in human glioma cells. Proc Natl Acad Sci U S A (1984) 1.14
Platelet-activating factor induces tyrosine phosphorylation in human neutrophils. J Biol Chem (1991) 1.14
Independent influence of gait speed and step length on stability and fall risk. Gait Posture (2010) 1.14
Biosynthesis of long-chain (sphingoid) bases from serine by LM cells. Evidence for introduction of the 4-trans-double bond after de novo biosynthesis of N-acylsphinganine(s). J Biol Chem (1986) 1.13
Immediate and latent interlimb transfer of gait stability adaptation following repeated exposure to slips. J Mot Behav (2008) 1.12
The randomized placebo-phase design for clinical trials. J Clin Epidemiol (2001) 1.12
An intermediate filament-associated protein, p50, recognized by monoclonal antibodies. J Cell Biol (1983) 1.11
Regulatory network motifs and hotspots of cancer genes in a mammalian cellular signalling network. IET Syst Biol (2007) 1.11
Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells. Toxicol Appl Pharmacol (1992) 1.10
Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion. J Biol Chem (1995) 1.10
Interferon increases the abundance of submembranous microfilaments in HeLa-S3 cells in suspension culture. Proc Natl Acad Sci U S A (1981) 1.09
A modified procedure for fast purification of T7 RNA polymerase. Protein Expr Purif (1999) 1.09
Alteration in sphingolipid metabolism: bioassays for fumonisin- and ISP-I-like activity in tissues, cells and other matrices. Nat Toxins (1999) 1.08
Surface array proteins of Campylobacter fetus block lectin-mediated binding to type A lipopolysaccharide. Infect Immun (1990) 1.07
Status of activation of circulating vaccine-elicited CD8+ T cells. J Immunol (2000) 1.07
Isolation and characterization of the rat chromosomal gene for a polypeptide (pS1) antigenically related to statin. J Biol Chem (1991) 1.07
Reduced thymic maturation but normal effector function of CD8+ T cells in CD8 beta gene-targeted mice. J Exp Med (1994) 1.07
A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr (1993) 1.07
Fumonisins and other inhibitors of de novo sphingolipid biosynthesis. Adv Lipid Res (1993) 1.06
The immunologic aspects of poxvirus oncolytic therapy. Cancer Immunol Immunother (2009) 1.06
CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2. Br J Cancer (2013) 1.06
Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats. Carcinogenesis (1992) 1.06